Ascletis ends first trading week on downturn
Ascletis Pharma Inc. (HKSE:1672) sank HK$1.84 (16%) to HK$10.02 on Friday, ending its first week of trading down 28% from its IPO price of HK$14.
This week, Ascletis became the first biotech to go public on the Hong Kong exchange since Hong Kong Exchanges and Clearing Ltd. (HKEX) created a new prerevenue chapter, opening the door for biotechs to list (see "First Out the Gate")...